Announcements 2020-21

Home / Announcements 2020-21

Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 22-10-2020

Compliance with requirement of Good Manufacturing Practice Guideline (GMP) of the Drug Administration of Vietnam 19-10-2020

Received product registration licenses for two products from the Ministry of Health, Cambodia 19-10-2020

Notice/ Intimation of loss/ misplace of share certificate 10-10-2020

Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 07-10-2020

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020 06-10-2020

Notice for closure of trading window 29-09-2020

Notice/ Intimation regarding issue of Duplicate Share Certificates 28-09-2020

Voting results of 20th Annual General Meeting held on September 26, 2020 27-09-2020

Outcome of 20th Annual General Meeting held on September 26, 2020 27-09-2020

Notice/ Intimation of Loss/ Misplace of Share Certificate 14-09-2020

Appointed as the Official Life-Care Partner of Chennai Super Kings & Royal Challengers Bangalore 10-09-2020

Renewal of Letter of Approval for SEZ unit 09-09-2020

Launching of new store segment “DAVAINDIA AYURVEDA & WELLNESS” under brand DAVAINDIA 04-09-2020

Newspaper Advertisements for 20th Annual General meeting of the Company 02-09-2020

Newspaper Advertisements for Public Notice of 20th Annual General Meeting 27-08-2020

Communication to Shareholders – Intimation of change in Income Tax Rules w.r.t Tax Deduction on Dividend 26-08-2020

Newspaper Advertisements for extract of Unaudited Financial Results for the quarter ended June 30, 2020 26-08-2020

Change in Address & Contact details of Registrar and Share Transfer Agent (RTA) 25-08-2020

Notice convening 20th Annual General Meeting of the Company 25-08-2020

Notice of Book Closure for Final Dividend and 20th Annual General Meeting 25-08-2020

Statement of Deviation and/ or Variation, if any, in the IPO fund utilization 25-08-2020

Copy of Newspaper Publication with regards to notice of Board meeting to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2020 18-08-2020

Received product registration licenses for two products from Uzbekistan 14-08-2020

Received product registration licenses for three products from Uzbekistan 07-08-2020

Compulsory transfer of unclaimed/ unpaid dividend of financial year 2012-13 to the Investor Education and Protection Fund 04-08-2020

“Record-break” 180 Agreements signed for new DAVAINDIA Stores during the month of July, 2020 01-08-2020

Certificate under Regulations 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2020 09-07-2020

Executed Exclusive Manufacturing and Supply Agreement for Co-Branding of the Brand “KHADI” as “ZOTA – KHADI” & “DAVAINDIA – KHADI” with Everyday Herbal Beauty Care & Vansh Trade Link 02-07-2020

Secretarial Compliance Report for the financial year ended March 31, 2020

Notice for Closure of Trading Window 29-06-2020

Received product registration licenses for six products from Turkmenistan 27-06-2020

List of Related Party Transactions for the half year and year ended March 31,2020 26-06-2020

Amendment in Code under SEBI (PIT) Regulations, 2015 23-06-2020

Statement of Deviation and/ or Variation, if any, in the IPO fund utilization 23-06-2020

Received product registration licenses for three products from the Ministry of Health, Cambodia 05-06-2020

Impact of COVTD-19 on Company’s Business Operations 02-06-2020

Press Release – Zota Health Care’s efforts in combating with Coronavirus 25-05-2020

Non-Applicability of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 with regards to fund raising by issuance of Debt Securities by Large Entities 08-05-2020

Reply to the clarification sought on the Announcement dated April 28, 2020 w.r.t. launching of COROVYL 29-04-2020

Launched new product with the name COROVYL for Viral Infection 28-04-2020

Resumption of operations at our manufacturing facility located at Sachin Special Economic Zone (SEZ) and Business Update 17-04-2020

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2020 15-04-2020

Disclosure under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the year ended on March 31, 2020 03-04-2020